HP-3060: Phase II started

Hisamitsu began a placebo-controlled Phase II trial to evaluate HP-3060 in adults with allergic rhinitis. Hisamitsu plans to start a Phase III trial of HP-3060 during its FY14 ending Feb. 28, 2014. ...